Market research
GHG.F Global Hemp Group Inc
F EUR Healthcare
Latest close
Latest stored close unavailable
Test a moving-average rule with historical data.
Market facts
- Market cap
- 105K
- P/E ratio
- Not available
- Analyst target
- Not available
- Dividend yield
- 0.0%
- Beta
- 1.78
Profile
Instrument facts
- Exchange
- F
- Currency
- EUR
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
- ISIN
- CA37953Y2033
- Market cap
- 105K
- P/E ratio
- Not available
- Analyst target
- Not available
- Dividend yield
- 0.0%
- Beta
- 1.78
About
About Global Hemp Group Inc
Global Hemp Group Inc. produces and processes industrial hemp in the United States. It focuses on the development of sustainable and green value-added industrial hemp products utilizing the processing of the hemp plant for multi-merchantable applications. The company was formerly known as Arris Holdings Inc. and changed its name to Global Hemp Group Inc. in March 2014. Global Hemp Group Inc. was incorporated in 2009 and is headquartered in North Vancouver, Canada.
Research context
Global Hemp Group Inc appears in PyInvesting’s Frankfurt Stock catalogue. The price history above describes this recorded instrument; it does not by itself identify a company’s business or establish a continuous investment return.
- Currency
- EUR
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
These are the latest stored catalogue classifications, not a historical classification snapshot. An issuer description, classification effective date or currency may be unavailable. Check the issuer’s own disclosures and the observation dates before using these fields for research.
Review backtest assumptions and evidence before treating a chart or stored history as a research result.
Community
Investor discussion
1 comment
Sign in to join the GHG.F discussion.
5 years, 7 months ago
Global Hemp Group Inc is currently in a long term uptrend where the price is trading 26.3% above its 200 day moving average.
From a valuation standpoint, the stock is 76032.0% more expensive than other stocks from the Healthcare sector with a price to sales ratio of 1000000.0.
Global Hemp Group Inc's total revenue sank by 100.0% to $0 since the same quarter in the previous year.
Its net income has increased by 80.3% to $-200K since the same quarter in the previous year.
Finally, its free cash flow fell by 466.6% to $-370K since the same quarter in the previous year.
Based on the above factors, Global Hemp Group Inc gets an overall score of 2/5.